chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the patient received the vaccines, the patient walked to the lobby, to wait 15 minutes before leaving. After a couple minutes (1 or 2) the patient fainted, and had loss of control of the bowel and bladder. The doctor was called, the patient awoke within minutes, and was observed for an additional 30 min. No additional reaction was noted.
Low grade fever, hot/cold sweats, muscle/bone aches, weakness, no appetite, able to take fluids only and bed rest.
CT showed that she had likely passed a gallstone and had pancreatitis; CT showed that she had likely passed a gallstone and had pancreatitis; seriously ill (serum calcium was 5.2), electrolytes all very low; seriously ill (serum calcium was 5.2), electrolytes all very low; difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the second dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in Arm Right on 16Apr2021 10:00 (at the age of 37 years old) (Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient took her first dose of BNT162B2 administered to right arm on 26Mar2021 08:00 and experienced mild bout of pancreatitis. suspected gallstone and vomiting on 02Apr2021 07:30. Facility where the most recent COVID-19 vaccine was administered was at Pharmacy or Drug Store. Patient has no known allergies. The patient did not have COVID-19 prior to the vaccination. No prior medical history to the pancreatitis/gallstone events after the vaccine doses. Patient has not taken any other vaccine in four weeks nor other medications in two weeks. The patient was not pregnant at the time of vaccination. One week exactly after patient received the first dose of the vaccine reported as 02Apr2021 07:30, she had a mild bout of pancreatitis and suspected gallstone. Patient's vomiting lasted 7 hours. At the time, she thought it was a short-lived stomach bug, but when the same thing happened after the second dose of the vaccine, it was more severe and patient ended up in the hospital for a week. Patient never had gallbladder or pancreas issues prior to these two events. 3 weeks after her second dose reported as 09May2021 16:00, patient got severely ill, resisted going to the hospital a few days hoping it was another stomach bug. When she ended up in the ER, she was seriously ill (serum calcium was 5.2), electrolytes all very low, difficulty breathing despite a clear chest X-ray and CT scan of my lungs. Another CT showed that she had likely passed a gallstone and had pancreatitis. She spent about a week in the hospital while treatment was focused on stabilizing patient's electrolytes (Electrolytes by IV). She needed to have her gallbladder removed but was sent home to continue recovering as she couldn't undergo an operation while she was still having difficulty breathing. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient has not been tested for COVID, post vaccination. The outcome of the event was recovering at the time of report.   Information on the lot/batch number has been requested.
I experienced a irregular heartbeat that lasted for hours and eventually I went to the ER and they diagnosed me with Atrial fibrillation and my heart rate was very low.
Received the Tdap and 4 days later noticed some swelling and redness around the site.  This extended down her arm and was warm and slightly tender.
arm soreness, fatigue,sleepiness, loss of appetite Narrative:  Patient had mild adr to second dose of COVID-19 vaccine(moderna) but all resolved by by 48 hours as per chart notes from 2/10/21
feeling very weak; lower back aches which then resulted in her aching everywhere at night; body aches from her head to her toes; feels like it's the flu or as if she was hit by a truck; sinuses are messed up; face feels a bit swollen; tighter lump at the injection site; headaches; injection site very sore; fever of 101; achy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feeling very weak), MYALGIA (achy), BACK PAIN (lower back aches which then resulted in her aching everywhere at night), PAIN (body aches from her head to her toes) and INFLUENZA LIKE ILLNESS (feels like it's the flu or as if she was hit by a truck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ASTHENIA (feeling very weak), MYALGIA (achy), BACK PAIN (lower back aches which then resulted in her aching everywhere at night), PAIN (body aches from her head to her toes), INFLUENZA LIKE ILLNESS (feels like it's the flu or as if she was hit by a truck), SINUS DISORDER (sinuses are messed up), SWELLING FACE (face feels a bit swollen), HEADACHE (headaches), VACCINATION SITE INDURATION (tighter lump at the injection site), VACCINATION SITE PAIN (injection site very sore) and PYREXIA (fever of 101). At the time of the report, ASTHENIA (feeling very weak), MYALGIA (achy), BACK PAIN (lower back aches which then resulted in her aching everywhere at night), PAIN (body aches from her head to her toes), INFLUENZA LIKE ILLNESS (feels like it's the flu or as if she was hit by a truck), SINUS DISORDER (sinuses are messed up), SWELLING FACE (face feels a bit swollen), HEADACHE (headaches), VACCINATION SITE INDURATION (tighter lump at the injection site), VACCINATION SITE PAIN (injection site very sore) and PYREXIA (fever of 101) outcome was unknown.            Concomitant product information was not provided by the reporter.  Treatment information was not provided.
Eye surgery; This spontaneous case was reported by a consumer and describes the occurrence of EYE OPERATION (Eye surgery) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE OPERATION (Eye surgery). At the time of the report, EYE OPERATION (Eye surgery) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
This spontaneous report as received from a nurse reporting that unspecified number of patients (no patient demographics known) were most likely vaccinated with M-M-R II which went out of temperature range and were exposed to temperature condition not supported by their in house stability data. No adverse effects reported. This is one of the several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 10-JUL-2017 the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot number M037770  expiration date: 01-JUL-2019, lot number: N004798 expiration date: 31-OCT-2018) for prophylaxis (digital data logger). No adverse effects reported. ; Sender's Comments: US-009507513-1708USA002800:
Pfizer-BioNTech COVID-19 Vaccine EUA: Approximately 10 minutes after receiving vaccine patient reported itching in her right arm and back and traveled to the rest of her body. Patient sat in chair with vital signs: blood pressure 133/70 mmHg, oxygen saturation 96%, temperature 97.3 degrees Fahrenheit, respiratory rate 18 breaths per minute, and heart rate of 62 beats per minute.  Diphenhydramine 25mg  oral liquid administered and at 6:54 am patient stated reaction started to go away. Repeat vital signs: blood pressure 128/68 mmHg, heart rate 68 beats per minute, respiratory rate 16 breaths per minute, oxygen saturation 97%. Patient left vaccine clinic independently in stable condition.
I experience a violent episode of Functional Neurological Disorder 24 hours after my Pfizer booster vaccination.  It reminded me of taking care of Parkinson patients except it was much worse than their tremors.  At the same time, I also got my flu shot and second shingles vaccination.  The shaking was also worse than the Grand Maul Seizers I have seen.  I was asleep when they started at 1:30 AM.  The complete episode lasted 45 minutes to an hour.  About half way thru the episode I was asking myself how long I would let this go on before calling EMS.    I got the shots at 11:30 AM and before going to bed at about midnight.   I had a nightcap of about ¼ to 1/3 cup of 80 proof vodka in about eight fluid ounces of juice. I wanted to let you know I had a lot of trouble saving this document.  I filled it out completely, clicked on the save button and then read the instructions and clicked on the link to submit the document.  That action wiped out all the information on the form and I had to start over and just filled out the abbreviated form.    YOUR WEBSITE ISN'T WORTH A CRAP.  There have to be a lot of people who tried to submit and then gave up.  Your drop down menu for medications is unreadable.  Before you put this crap up for people to use don't you have two or three people try it out first with out someone standing over their shoulder correcting their mistakes as they fill it out?
Rash on upper left arm spreading from injection site to inner arm; also on back of same arm. Red, slightly swollen, itchy, hot, slightly painful. Treatment: ice pack, antihistamine, lasting over a week
Narrative:  COVID infections following completion of COVID vaccine series 02/06/21 COVID vaccine dose #1 02/24/21 COVID vaccine dose #2 07/26/21 Pt presents to screening reporting of cough; COVID POSITIVE 07/27/21 Pt reports intermittent cough; rx given for vitamin C, zinc, vitamin D 07/28/21 Pt reports runny nose, fatigue 07/30/21 Pt reports minimal cough and resolved runny nose 08/01/21 Pt reports all symptoms have improved and is afebrile; states symptoms started 07/24; clinically resolved
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient did not experience temperature excursion previously. On 26-APR-2016 the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (dose and route were unknown, lot # L050910, expiration date: 14-JUN-3017, therapy type: digital data logger). The vaccine was exposure on 9.9 Fahrenheit (F) for 1 hours and 20 minutes. No adverse events were reported. This case was one of several cases received from the same reporter. Additional information has been requested.
below vaccine site (left deltoid) with 9cmx9cm area of redness, swelling, increased warmth
feel very weak; unstable walking; I am wondering; feel very weak, unstable walking and I don't know if it may be in my stomach too, I am feeling upset feeling in my stomach; This is a spontaneous report from a contactable consumer (Patient herself). A 90-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Not reported, Expiration date: 31May2021) via unspecified route of administration on 02Feb2021 at SINGLE DOSE for COVID-19 Immunization. The patients medical history was not reported. Concomitant medication included vitamins. The patient stated I am wondering; feel very weak, unstable walking and I don't know if it may be in my stomach too, I am feeling upset feeling in my stomach. The patient did not receive treatment medication. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
3" raised red spot at injection spot; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199) via unspecified route of administration in the left arm on 11Mar2021 at 15:45(at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. The patient had allergies to unspecified medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 20Mar2021 at 16:45, the patient had 3 degree raised red spot at injection spot (vaccination site erythema). The patient did not receive any treatment for the event. The clinical outcome of the event 3 degree raised red spot at injection spot was not recovered at the time of this report.   No follow-up attempts are possible; No further information is expected.
This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Jan2021 at single dose for covid-19 immunisation, ibuprofen sodium (IBUPROFEN [IBUPROFEN SODIUM]), via an unspecified route of administration from an unspecified date to an unspecified date at unknown dosage for an unspecified indication. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient was in bed now and he has got aches and pains like muscle pain throughout his body. Outcome of events was unknown. MInformation about Lot/Batch number is requested.
The first thing I noticed was that I had a headache. I took a COVID-19 home test on May 04, 2022, and it was positive. I was tired so I took a half day off work. Then I felt better the next day. Over the next couple of months, I developed a cough that would not go away. After listening to my lungs, she prescribed me an albuterol inhaler and benzonatate for the cough. She did indicate that she heard wheezing in my lungs. I took the medicine and used the inhaler for about 5 weeks. Then the coughing just stopped. I have since had another breakthrough case after this 3rd dose. My coworkers tested positive, so I took a test the next day and tested positive on 09/15/2022 with an at home test. Friday and Saturday I have a low-grade fever of about 100 degrees. I felt crappy, worn down and slightly feverish. I emailed my doctor, and they told me to see how the weekend went so by Monday I was feeling normal again. A few weeks ago, I developed the cough again, but it is much milder. I haven't had to use the inhaler again though. I feel like I have recovered but randomly I have this cough. Other than that, I feel like I am at 100 percent.
He broke out in a rash mostly on the arms rash clear in a few days. Used cream for rash to clear.
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning a 20-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 01-Jan-2012. On 04-Jan-2012, the patient inadvertently received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Rash on inner thighs.; Both thighs small pimple like rash.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 03Apr2021 at 12:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00, the patient experienced rash on inner thighs, appeared next day and both thighs small pimple like rash that eased after a couple of days but still there a little bit.  No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not  been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events rash on inner thighs, appeared next day and both thighs small pimple like rash was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
pt recvd vax;devel T 103,irritability p/DTP vax;devel red itchy area on inject arm p/ MMR vax,described as a red flushing all over arm;tx:dph;pt recovered
Clinical staff member (no longer works for this office) mixed the dry menveo with a diluent that did not go with the menveo. Patient did not get full vaccine.
Information has been received from a pharmacist refers to patients of unknown age and gender who were enrolled in a market research program. On an unknown date the reporter had seen or heard that the PNEUMOVAX was recommended as the second dose in a series and PREVNAR should be given first for patients. The outcome of event was unknown. Additional information is not expected as the reporter was not wiling to be contacted.
t; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received first primary series of Moderna Covid-29 vaccine as the bivalent booster instead of the monovalent vaccine.) and NO ADVERSE EVENT (No adverse event) in a 40-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.       It was stated that no other adverse events were reported. No concomitant information was reported. No treatment information was provided.
Narrative: 72 yo patient with long history of crack cocaine use died on 9/21/2021. Pt did not receive medical care from agency. No information, not even vitals or weight or allergy posted. Pt did receive covid vaccines from a different place. Place pt received vaccines in unknown. Pt received vaccines on 2/20/21 & 3/18/21. Likely this death is not related to vaccines due to length of time from vaccine administration.
This spontaneous report as received from a registered nurse refers to unspecified amount of patients. On an unknown date the patients were vaccinated with improperly stored VARIVAX. Administration route, date and lot number were not reported. The nurse reported that the VARIVAX was exposed to a temperature of 1.4C for 30 hours. She also reported that the VARIVAX had multiple excursions in which it was exposed to a temperature between above -15C to -10C for an unspecified amount of hours which she "believes" was due to defrost cycles. No adverse effect reported. This is one of three reports received from the same source. Additional information has been requested.
Extreme shortness of breath, which last for approximately 4 days.  Patient had no history of shortness of breath and has had no recurrence.
PATIENT REPORTED ON 08/08/2021 THAT HE RECEIVED SHINGRIX VACCINE ON 08/03/2021. THE PATIENT STATES HIS ARM AT THE INJESTION SITE WAS SORE FOR APPROX. 2 DAYS AND NOW A ONE INCH CIRCUMFERENCE AROUND INJECTION SITE IS NUMB.
Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
pt recvd vax for prophylaxis;w/in secs of adm of vax,exp dizziness,a metallic taste in mouth,and chills;pt tx w/ O2;events subsided approcx 3 hrs p/ onset;
That day, felt bad and had migraine. 4 days later, she had numbness and stiffness in hands, slowly improved over several weeks. She also had heart racing- went to ED because thought having MI.
Very tired day of injection with sore arm. The 15th, 3 days after shot arm, is very red and tender with a rash like area about 4? x 6?. Splotchy and warm.
Blood pressure went up to 170 /100; Numbing of my neck and left side of my face to my nose; Increased pulse rate; back and head itching; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm left on 29Mar2021 09:15 (Batch/Lot number: ER8734) (at the age of 64-year-old) as 1st dose, single for COVID-19 immunisation. Medical history included allergies to dairy, cats, sulfa drugs, seasonal allergies and blood pressure. The patient was on unspecified medication (received within 2 weeks of vaccination) to control blood pressure. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 09:30, within 15 minutes of injection, the patient had numbing of neck and left side of my face to my nose and blood pressure went up to 170 /100. 12 hours later back and head itching, afterwards but now it seems to be calm down and had increased pulse rate. Due to events patient visited doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with Benadryl. The outcome of the event increased pulse rate was unknown, and all other events was recovered on an unknown date in 2021.  Follow-up attempts are needed. Further information is expected.
A report was received from a health professional on 11/16/2001 concerning a 50 year old male patient who experienced persistent lightheadedness 5 days after receiving Fluvirin on 11/07/2001. On 11/12/2001 the patient developed lightheadedness that had persisted since onset. The patient did not have a fever or exhibit any flu-like symptoms. The patient's blood pressure and pulse were normal and a neurological exam was normal. The patient was not receiving treatment for lightheadedness at the time of the report. The reporter's causality assessment was recorded as possible.
This spontaneous report as received from a nurse refers to a multiple unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with doses of PEDVAXHIB (dose, lot number, expiration date were not reported) for prophylaxis that were stored improperly. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
injection site soreness; chills; muscle pain; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  A female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Lot number: FK9893) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid vaccine (DOSE 2, MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid vaccine (DOSE 3 (BOOSTER), MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "injection site soreness"; CHILLS (non-serious), outcome "unknown"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain".  Additional information: Female experienced events following second booster dose of COVID-19 vaccine. Event took place after use of product.  No follow-up attempts are possible. No further information is expected.